Antagonistic effect of C19 on migration of vascular smooth muscle cells and intimal hyperplasia induced by chemokine-like factor 1

C-terminal peptides of chemokine-like factor 1 signal through chemokine receptor CCR4 to cross-desensitize the CXCR4

(2011) Yan Zhang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Alleviation of murine allergic rhinitis by C19, a C-terminal peptide of chemokine-like factor 1 (CKLF1)

(2011) Yi Zheng et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

C19, a C-terminal peptide of chemokine-like factor 1, protects the brain against focal brain ischemia in rats

(2011) Ling-Lei Kong et al.   NEUROSCIENCE LETTERS

The CKLF1-C19 peptide attenuates allergic lung inflammation by inhibiting CCR3- and CCR4-mediated chemotaxis in a mouse model of asthma

(2010) L. Tian et al.   ALLERGY

Expressional and functional studies of CKLF1 during dendritic cell maturation

(2010) Luning Shao et al.   CELLULAR IMMUNOLOGY

Chemokine-like factor expression in the idiopathic inflammatory myopathies

(2008) M. H. Chowdhury et al.   ACTA NEUROLOGICA SCANDINAVICA

Chemokines in Vascular Dysfunction and Remodeling

(2008) Andreas Schober   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Preventing restenosis after angioplasty: a multistage approach

(2008) Ramin Zargham   CLINICAL SCIENCE

Chemotaxis, chemokine receptors and human disease

(2008) Tian Jin et al.   CYTOKINE

Two C-terminal peptides of human CKLF1 interact with the chemokine receptor CCR4

(2007) Ying Wang et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY